Seeking safe stool: Canada needs a universal donor model
Carolyn Edelstein, Jamie R. Daw, Zain Kassam
Abstract
Open-access reader
Carolyn Edelstein, Jamie R. Daw, Zain Kassam
Abstract
Open-access reader
Early in 2015, Health Canada opened the door to fecal microbiota transplantation, a promising treatment for patients with recurrent Clostridium difficile infection.[1][1] During fecal microbiota transplantation, stool from a healthy, screened donor is homogenized and filtered and is either infused
OpenAlex reports 24 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Early in 2015, Health Canada opened the door to fecal microbiota transplantation, a promising treatment for patients with recurrent Clostridium difficile infection.[1][1] During fecal microbiota transplantation, stool from a healthy, screened donor is homogenized and filtered and is either infused
Key concepts: Fecal bacteriotherapy, Clostridium difficile, Feces, Medicine, Clostridium Infections, Transplantation, Intensive care medicine, Immunology